Given your 2023 cost effectiveness model and the 2022 stakeholder- perception study, I’m curious whether you think the future of PGx research should track patient -reported outcomes such as trust, satisfaction or perceived empowerment beyond clinical metrics?
Given your 2023 cost effectiveness model and the 2022 stakeholder- perception study, I’m curious whether you think the future of PGx research should track patient -reported outcomes such as trust, satisfaction or perceived empowerment beyond clinical metrics?